BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer.
- Published in:
- Medical Oncology, 2016, v. 33, n. 5, p. 1, doi. 10.1007/s12032-016-0756-6
- By:
- Publication type:
- Article
Works matching IS 13570560 AND DT 2016 AND VI 33 AND IP 5
Results: 15
1
2
Clinical significance of circulating miRNA detection in lung cancer.
- Published in:
- Medical Oncology, 2016, v. 33, n. 5, p. 1, doi. 10.1007/s12032-016-0757-5
- By:
- Publication type:
- Article
3
Cyclin D1 and cyclin E2 are differentially expressed in gastric cancer.
- Published in:
- Medical Oncology, 2016, v. 33, n. 5, p. 1, doi. 10.1007/s12032-016-0754-8
- By:
- Publication type:
- Article
4
Targeting persistent androgen receptor signaling in castration-resistant prostate cancer.
- Published in:
- Medical Oncology, 2016, v. 33, n. 5, p. 1, doi. 10.1007/s12032-016-0759-3
- By:
- Publication type:
- Article
5
Inhibition of glioblastoma cell proliferation, migration and invasion by the proteasome antagonist carfilzomib.
- Published in:
- Medical Oncology, 2016, v. 33, n. 5, p. 1, doi. 10.1007/s12032-016-0767-3
- By:
- Publication type:
- Article
6
Peptide receptor radionuclide therapy for metastatic paragangliomas.
- Published in:
- Medical Oncology, 2016, v. 33, n. 5, p. 1, doi. 10.1007/s12032-016-0737-9
- By:
- Publication type:
- Article
7
Cost description of chemotherapy regimens for the treatment of metastatic pancreas cancer.
- Published in:
- Medical Oncology, 2016, v. 33, n. 5, p. 1, doi. 10.1007/s12032-016-0762-8
- By:
- Publication type:
- Article
8
Hypoxia regulates stemness of breast cancer MDA-MB-231 cells.
- Published in:
- Medical Oncology, 2016, v. 33, n. 5, p. 1, doi. 10.1007/s12032-016-0755-7
- By:
- Publication type:
- Article
9
Multi-kinase inhibitors, AURKs and cancer.
- Published in:
- Medical Oncology, 2016, v. 33, n. 5, p. 1, doi. 10.1007/s12032-016-0758-4
- By:
- Publication type:
- Article
10
Potential of sulfasalazine as a therapeutic sensitizer for CD44 splice variant 9-positive urogenital cancer.
- Published in:
- Medical Oncology, 2016, v. 33, n. 5, p. 1, doi. 10.1007/s12032-016-0760-x
- By:
- Publication type:
- Article
11
FGFR3 promotes angiogenesis-dependent metastasis of hepatocellular carcinoma via facilitating MCP-1-mediated vascular formation.
- Published in:
- Medical Oncology, 2016, v. 33, n. 5, p. 1, doi. 10.1007/s12032-016-0761-9
- By:
- Publication type:
- Article
12
Assessment of the frequency of genetic alterations (LOH/MSI) in patients with intraepithelial cervical lesions with HPV infection: a pilot study.
- Published in:
- Medical Oncology, 2016, v. 33, n. 5, p. 1, doi. 10.1007/s12032-016-0763-7
- By:
- Publication type:
- Article
13
Risk of interactions between complementary and alternative medicine and medication for comorbidities in patients with melanoma.
- Published in:
- Medical Oncology, 2016, v. 33, n. 5, p. 1, doi. 10.1007/s12032-016-0764-6
- By:
- Publication type:
- Article
14
HDAC6-mediated EGFR stabilization and activation restrict cell response to sorafenib in non-small cell lung cancer cells.
- Published in:
- Medical Oncology, 2016, v. 33, n. 5, p. 1, doi. 10.1007/s12032-016-0765-5
- By:
- Publication type:
- Article
15
Translating microRNAs into biomarkers: What is new for pediatric cancer?
- Published in:
- Medical Oncology, 2016, v. 33, n. 5, p. 1, doi. 10.1007/s12032-016-0766-4
- By:
- Publication type:
- Article